Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- KU LEUVEN
- Ghent University
- University of Antwerp
- VIB
- Vrije Universiteit Brussel
- Nature Careers
- University of Leuven
- IMEC
- Université Libre de Bruxelles (ULB)
- Vrije Universiteit Brussel (VUB)
- Hasselt University
- BIO BASE EUROPE PILOT PLANT VZW
- Flanders Institute for Biotechnology
- Ghent University;
- Univeristé Libre de Bruxelles
- University of Liège
- Université catholique de Louvain (UCL)
- Université libre de Bruxelles (ULB)
- Université libre de Bruxelles - Service BATir
- 9 more »
- « less
-
Field
-
in financial and economic law. For this function, our Brussels Humanities, Sciences & Engineering Campus (Elsene) will serve as your home base.
-
assessment. Moreover, post-mortem studies have revealed significant molecular heterogeneity, suggesting the existence of distinct neuropathological subtypes within each disease. Stratifying patients
-
, Sciences & Engineering Campus (Elsene) will serve as your home base.
-
patients’ brain, molecular diagnosis during life remains challenging due to the lack of reliable biomarkers for in vivo assessment. Moreover, post-mortem studies have revealed significant molecular
-
, rigorous, solution-oriented and a critical thinker. Attention to quality, integrity, creativity and cooperation. Teaching competences that are in line with the University of Antwerp’s educational vision /VIB
-
in vitro and in living cells The applicant will benefit from access to centralized facilities (in particular Nanobody technology, proteomics, cutting-edge microscopy and structural biology). Please
-
leadership, the successful candidate will: Enroll to the doctoral programme of the University and undertake research in the field of European law leading to the award of the PhD degree Participate and
-
. For further information and questions, please send an email to Prof. Jonathan Maelfait (jonathan.maelfait@irc.vib-ugent.be ).
-
for five years, from November 30, 2023, to November 30, 2028. Under this agreement, UGent and CSC co-finance about 50 new CSC PhD students annually. Students selected through the UGent-CSC preference program
-
(IRDs) are an important cause of early vision loss and blindness. Among these, mutations in the PRPH2 gene are particularly common and affect up to 200,000 patients worldwide. However, PRPH2-related